(1R,2R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclobutane-1-carboxylic acid, 97%, 100mg

HPLC column NUCLEODUR® 300-5 C4 ec, 250 mm, 4.6 mm, 1 Piece(s)

2[2-(4-Fluorophenyl)-2-oxo-1-phenylethyl]-4-methyl-3-oxo-pentanoic acid phenylamide, 95.0%, 500g

(S)-2-(3,4-Dimethylphenyl)piperidine, 95.0%, 250mg

2,5-Dichloroquinoline, 95.0%, 10g

4,4,5,5-Tetramethyl-2-(4-(methylthio)phenyl)-1,3,2-dioxaborolane, 95.0%, 5g

Ethyl 5-oxo-5-(4-pyridyl)valerate, 97.0%, 1g

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-5-carbonitrile, 98%, 5g

5-(4-fluorophenyl)-1,2,4-thiadiazol-3-amine, 95.0%, 500mg

6-Chloro-2-(trifluoromethyl)nicotinic acid, 97.0%, 5g

6,7-Dihydro-5H-pyrrolo[1,2-c]imidazol-7-ol, 98%, 50mg

1-Boc-5-Cyano-3-formylindole, 95.0%, 1g

(1R,2R)-(+)-1,2-Diphenylethylenediamine, 98.0%, 1g